Randomized, open-labeled study of prophylactic vs. therapeutic use of Uroxatrol to determine improvements in urinary morbidity following men undergoing prostate brachytherapy
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Alfuzosin (Primary)
- Indications Urinary retention
- Focus Therapeutic Use
- 14 Feb 2008 The expected completion date for this trial is now 1 Sep 2005.
- 25 Sep 2006 New trial record.